-+ 0.00%
-+ 0.00%
-+ 0.00%

Beyond Air sells NeuroNOS stake to Univo for 19.99% equity, up to $32.5 million milestones

PUBT·08/25/2026 11:02:42
Listen to the news
Beyond Air sells NeuroNOS stake to Univo for 19.99% equity, up to $32.5 million milestones
  • Beyond Air agreed to sell its 58% fully diluted stake in NeuroNOS Israel to UNIVO Pharmaceutical Industries.
  • Consideration includes UNIVO ordinary shares equal to 19.99% of UNIVO’s issued share capital at closing.
  • Beyond Air also to receive warrants tied to 19.99% of UNIVO’s outstanding options, warrants, and other awards, exercisable at $0.01 for five years.
  • An IP transfer agreement provides up to $6.5 million in cash development milestones tied to clinical, regulatory, and commercialization progress.
  • Additional commercial milestones of up to $26 million are payable upon specified net sales thresholds, taking total potential milestones to $32.5 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Air Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608250700PRIMZONEFULLFEED9815361) on August 25, 2026, and is solely responsible for the information contained therein.